Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Arcturus Therapeutics Holdings Inc
(NQ:
ARCT
)
18.24
+0.34 (+1.90%)
Streaming Delayed Price
Updated: 12:22 PM EST, Dec 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arcturus Therapeutics Holdings Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Japan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics’ ARCT-154, the First Self-Amplifying mRNA Vaccine Approved for COVID in Adults
November 28, 2023
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics Receives Orphan Drug Designation from the U.S. FDA for ARCT-032, for the Treatment of Cystic Fibrosis
November 27, 2023
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Target Reports Earnings Beat, Joins AST SpaceMobile, Dada Nexus And Other Big Stocks Moving Higher On Wednesday
November 15, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Wednesday. Shares of Target Corporation (NYSE: TGT) jumped during Wednesday’s session after the company reported...
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
Arcturus Therapeutics: Q3 Earnings Insights
November 14, 2023
Via
Benzinga
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
November 15, 2023
Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results.
Via
Benzinga
Why CorMedix Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket
November 15, 2023
Shares of CorMedix Inc. (NASDAQ: CRMD) surged in pre-market trading as the company posted a narrower-than-expected third-quarter loss. Cormedix posted a loss of 17 cents per share for the third...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 15, 2023
It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news worth reading about on Wednesday!
Via
InvestorPlace
Arcturus Therapeutics Announces Third Quarter 2023 Financial Update and Pipeline Progress
November 14, 2023
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
The 3 Most Undervalued Biotech Stocks to Buy: November 2023
November 14, 2023
Given the undervalued biotech industry, these three undervalued biotech stocks to buy are ripe purchase targets for high-potential profits.
Via
InvestorPlace
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 14, 2023
October 25, 2023
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences
October 23, 2023
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded Additional Financial Grants from Japanese Government
October 04, 2023
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
A Look Into Healthcare Sector Value Stocks
October 02, 2023
Via
Benzinga
Arcturus Therapeutics and Cystic Fibrosis Foundation Extend Agreement to Advance ARCT-032, an Investigational Messenger RNA (mRNA) Therapeutic to Treat Cystic Fibrosis
September 26, 2023
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Study Shows Novel sa-mRNA Vaccines Offer Robust, Broad, Enduring Protection Against COVID-19 Variants
September 19, 2023
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics and CSL Announce European Medicines Agency Validates Marketing Authorization Application for ARCT-154 Vaccine to Prevent COVID-19
September 05, 2023
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics to Attend Upcoming Investor Conferences
August 17, 2023
From
Arcturus Therapeutics
Via
Business Wire
Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded $115 Million in Grants from the Japanese Government
August 14, 2023
From
Arcturus Therapeutics
Via
Business Wire
Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday
August 09, 2023
U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Shares of Arcturus Therapeutics Dropped on Tuesday
August 08, 2023
The company saw revenue decline and net losses rise in the second quarter.
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 08, 2023
Via
Benzinga
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 08, 2023
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser...
Via
Benzinga
Arcturus Therapeutics Announces Second Quarter 2023 Financial Update and Pipeline Progress
August 07, 2023
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Dynavax Technologies Stock Sees Renewed Technical Strength
August 07, 2023
Dynavax Technologies shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 84.
Via
Investor's Business Daily
3 Biotech Stocks to Buy Before the Breakout
July 28, 2023
Explosive growth and rapid innovation lie ahead for these three biotechnology stocks, making them the ones to watch.
Via
InvestorPlace
Arcturus Therapeutics to Report Second Quarter 2023 Financial Results and Provide Corporate Update on August 7, 2023
July 24, 2023
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Analyst Initiates Arcturus: Sees Attractive Growth Trajectory with Vaccine Franchise Despite Competition
July 24, 2023
William Blair analyst Myles Minter has initiated coverage of Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) with an Outperform rating and a fair
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023
July 24, 2023
Via
Benzinga
Amicus Therapeutics Stock Scores Healthy Relative Strength Upgrade
July 20, 2023
On Thursday, Amicus Therapeutics stock got an upgrade to its Relative Strength (RS) Rating, from 78 to 81.
Via
Investor's Business Daily
3 Biotech Stocks for Getting Rich in 2023
July 18, 2023
These 3 biotech stocks have seen stable or growing revenue this year. This makes them companies to keep on your watchlist.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.